Janux Therapeutics, Inc. (JANX) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of$0.6. This compares to a loss of $0.51 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +35.00$0.48 per share when it actually produced a loss of $0.55, delivering a surprise of -14.58%.Over the last four quarters, the company ...